openPR Logo
Press release

Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report Published By MarketResearchReports.biz

08-01-2016 08:33 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: MRR biz

MarketResearchReports.Biz announces addition of new report “ Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report” to its database.

Description

Recent months have seen the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a Supreme Court ruling affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends give clear indicators of what may happen in the industry in 2015 and beyond. Is it worth it to get informed about rapidly-evolving market conditions and identify key industry trends that will give you an advantage over your competition?

REPORT APPLICATIONS

This global strategic report is produced for:
Management of Stem Cell Product Companies
Management of Stem Cell Therapy Companies
Stem Cell Industry Investors

It is designed to increase your efficiency and effectiveness in:

Commercializing iPSC products, technologies, and therapies
Making intelligent investment decisions
Launching high-demand products
Selling effectively to your client base
Increasing revenue
Taking market share from your competition

OVERVIEW

Stem cell research and experimentation have been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more.

Traditionally, scientists have worked with both embryonic and adult stem cells for research tools, as well as for cellular therapy. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral, and spiritual controversy surrounding their use. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which results in fewer options for use.

Thus, induced pluripotent stem cells represent a promising combination of adult and embryonic stem cell characteristics.

Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/288620

Discovery of Induced Pluripotent Stem Cells

Groundbreaking experimentation in 2006 led to the introduction of induced pluripotent stem cells (iPSCs). These are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression, as well as other methods. Research and experimentation using mouse cells by Shinya Yamanaka’s lab at Kyoto University in Japan was the first instance in which there was successful generation of iPSCs. In 2007, a series of follow-up experiments was done at Kyoto University in which human adult cells were transformed into iPSC cells. Nearly simultaneously, a research group led by James Thomson at the University of Wisconsin-Madison accomplished the same feat of deriving iPSC lines from human somatic cells.

Over the next few years, iPSC research advances accelerated exponentially. 2013 was the first time in which clinical research involving transplant of iPSCs into humans was initiated, led by Masayo Takahashi of the RIKEN Center for Developmental Biology in Kobe, Japan. Dr. Takahashi and her team are investigating the safety of iPSC-derived cell sheets in patients with wet-type age-related macular degeneration. While the trial was initiated in 2013 and production of iPSCs from patients began at that time, it was not until August of 2014 that the first patient was implanted with retinal tissue generated using iPSCs derived from her own skin cells. Also, Kyoto University Hospital in Kobe, Japan announced in February of 2015 that it will be opening an iPSC therapy center in 2019, for purposes of conducting clinical studies on iPSC therapies.

Landmark Events Create Market Opportunities for iPSCs

In 2009 ReproCELL, a company established as a venture company originating from the University of Tokyo and Kyoto University, was the first to make iPSC product commercially available with the launch of human iPSC-derived cardiomyocytes, which it called “ReproCario.” ReproCELL has since furthered its dominance in the area of iPSC products through a series of strategic acquisitions, including acquisition of Reinnervate, Stemgent, and BioServe Biotechnologies.

Cellular Dynamics International (CDI) is another major market player in the iPSC sector. Similar to ReproCELL, CDI established its “foothold” on the iPSC industry early, being founded in 2004 by Dr. James Thomson at the University of Wisconsin-Madison, who in 2007 subsequently derived iPSC lines from human somatic cells for the first time ever (although the feat was also accomplished simultaneously by Dr. Shinya Yamanaka’s lab in Japan). CDI currently holds more than 800 patents, and the company went public in July 2013 with a public offering that raised $43 million dollars, securing its position as the global leader in producing high-quality human iPSCs and differentiated cells in industrial quantities.

Finally, Cellular Dynamics International (CDI) and the Coriell Institute for Medical Research received multi-million dollar grants ($16 million total) from the California Institute for Regenerative Medicine to create 3,000 iPSC lines from healthy and diseased donors, a result will create the world’s largest human iPSC bank.


In aggregate, there is incredible enthusiasm and investment driving growth of the iPSC sector, with recent years seeing major advances in clinical research applications, production and differentiation technologies, and biobanking of iPSCs. There have been major funding awards, large initial public offerings (IPOs), significant patent challenges, and more. For companies and investors competing within the iPSC marketplace, it is critical to understand these major market events and how they are shifting industry dynamics.

Browse Latest Industry Press Release at: http://www.marketresearchreports.biz/pressreleases

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Contact
Mr. Nachiket
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report Published By MarketResearchReports.biz here

News-ID: 353078 • Views: 556

More Releases from MRR biz

Sentiment Analysis Software Market Emerging Trends and Top Key Vendors to Watch- …
Sentiments analysis is also known as emotional artificial intelligence and opinion mining. Sentiment analysis software is used for processing of natural language, computational linguistics, biometrics, and text analysis to quantify, identify, and extract systematically. The sentiment analysis software is widely used to analyse the voice of the customer materials which includes survey and reviews responses collected from online and social media, and healthcare materials for applications that range from marketing
Innovation On The HetNet Ecosystem (Small Cells, Carrier Wi-Fi, C-RAN & DAS): 20 …
Driven by in-building wireless coverage requirements and the growing influx of mobile data traffic, a conventional macrocell based cellular network deployment is not deemed to be a sufficient solution to address the coverage and capacity needs of today’s wireless subscribers. Mobile operators are thus increasing their investments in Heterogeneous Network or HetNet infrastructure such as strategically deployed small cells, carrier Wi-Fi and DAS (Distributed Antenna Systems), to cope with growing capacity
Innovative Technology - Global RFID Smart Cabinet Market To grow at a CAGR of 14 …
About RFID More Details: http://www.marketresearchreports.biz/analysis/834778 RFID technologies are gaining high attention from multiple sectors, especially healthcare, where hospitals have started adopting innovative technologies to address critical business needs. Smart cabinets based on RFID technology help reduce manual efforts to maintain, track, and manage inventory. They also help reduce loss and misplacement of supplies, minimize the risk of theft, and increase savings. Retailers, healthcare institutions, and discrete manufacturers are the prime users of
Global Next Gen LMS Market Segments To Grow at CAGR of 26.51% Over Period 2016-2 …
About Next-Gen LMS Get More Details: http://www.marketresearchreports.biz/analysis/834773 A next-gen LMS is a software application used to plan, deliver, and manage the learning process. It uses web-based technology to manage, administer, track, report on the delivery, and evaluate the performance of participants. In addition to the functionalities of the traditional LMS, the next gen LMS addresses the following functional requirements: Interoperability which allows integration of tools and exchange of content Customization of learning process Inclusion of

All 5 Releases


More Releases for Stem

Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
MarketResearchReports.Biz adds “Global Stem Cell Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Stem Cell and the growth estimates for the forecasted period. Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Stem Cells Industry Forecast Report 2017-2022
ReportsWeb.com has announced the addition of the “United States Stem Cells Market Report 2017” The report focuses on United States major leading players with information such as company profiles, product picture and specification. Geographically, this report splits the United States market into seven regions: The West, Southwest, The Middle Atlantic, New England, The South and The Midwest. with sales (volume) , revenue (value) , market share and growth rate of Stem
Proceeding of Stem Cells in Asia-Pacific Stem Cell Market.
Asia-Pacific Stem Cell Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 15.5% to reach USD 7.15 billion by 2021, from USD 3.48 billion in 2016, which amounts to a cumulative growth of USD 3.67 billion. Stem cells are those cells that are maintained for a long time by remaining undifferentiated and sustained proliferation in a few parts of the body. Stem
STEM Summer Camp 2017
Join Mental Fitness for our second annual Summer of STEAM camp in South Fulton County. Our campers continue their learning in a fun and engaging way while still enjoying the summer! Your student will experience a half day of hands-on project based learning and a half day of good old fashion summer fun. High level concepts like electricity and magnetism, computer coding, environmental projects and more.